NEW YORK CITY, NY--(Marketwire - April 16, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF), a biomedical venture philanthropy, and Elan Corporation, plc (NYSE: ELN), a neuroscience-based biotechnology company, are pleased to announce the winners of their third annual research award program, Novel Approaches to Drug Discovery for Alzheimer's Disease. Four international scientists received a total of $530,000 in grant funding.
